Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,294 papers from all fields of science
Search
Sign In
Create Free Account
DNA Methyltransferase Inhibitors [MoA]
Known as:
DNA Methyltransferase Inhibitors
, DNA Methytransferase Inhibitors
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Azacitidine
DNA Methyltransferase Inhibitor
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Epigenetic Therapeutics and Their Impact in Immunotherapy of Lung Cancer
J. Cho
,
F. Oezkan
,
M. Koenig
,
G. Otterson
,
J. Herman
,
K. He
Current Pharmacology Reports
2017
Corpus ID: 3738808
Lung cancer is the leading cause of cancer-related death in the USA and worldwide. Novel therapeutic developments are critically…
Expand
2017
2017
DNA methyltransferase inhibitors influence on the DIRAS3 and STAT3 expression and in vitro migration of ovarian and breast cancer cells.
Ewa Nowak
,
Marta Poczęta
,
D. Bieg
,
I. Bednarek
Ginekologia Polska
2017
Corpus ID: 19589756
OBJECTIVES Downregulation of DIRAS3 (DIRAS family, GTP-binding Ras-like 3) is related to ovarian and breast cancer progression. A…
Expand
2016
2016
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes.
C. Finelli
,
M. Follo
,
+5 authors
L. Cocco
Current pharmaceutical design
2016
Corpus ID: 25183054
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic diseases, mainly affecting the elderly, characterized by…
Expand
2015
2015
Computational fishing of new DNA methyltransferase inhibitors from natural products.
W. Maldonado-Rojas
,
J. Olivero-Verbel
,
Y. Marrero-Ponce
Journal of Molecular Graphics and Modelling
2015
Corpus ID: 23303414
Review
2015
Review
2015
The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes
Abdallah Abou Zahr
,
Ehab Saad Aldin
,
Lisa Barbarotta
,
N. Podoltsev
,
A. Zeidan
Expert Review of Anticancer Therapy
2015
Corpus ID: 8208535
Myelodysplastic syndromes (MDS) include a heterogeneous group of acquired hematopoietic malignancies characterized by ineffective…
Expand
Review
2015
Review
2015
Epigenetic therapy for colorectal cancer.
Vivek Vaish
,
Tripti Khare
,
M. Verma
,
S. Khare
Methods in molecular biology
2015
Corpus ID: 41735517
Aberrations in epigenome that include alterations in DNA methylation, histone acetylation, and miRNA (microRNA) expression may…
Expand
2014
2014
Ingenol derivates promising for HIV eradication.
E. Poveda
AIDS Reviews
2014
Corpus ID: 1908663
The eradication of HIV is at this moment one of the greatest challenges in the fight against HIV/AIDS. Despite the prolonged…
Expand
2011
2011
Epigenetic manipulation of the immune response: a novel treatment strategy in hematologic malignancies.
C. Craddock
Cytotherapy
2011
Corpus ID: 2989305
Acquired abnormalities in chromatin structure are increasingly recognized as an important mechanism of leukemogenesis. In…
Expand
Review
2010
Review
2010
Prior Therapy with DNA Methyltransferase Inhibitors (DNMTI) Predicts for Lower Remission Rates and Worse Survival In Secondary Acute Myeloid Leukemia Patients (sAML) Receiving Remission Induction…
S. Mohan
,
A. Fu
,
+11 authors
M. Sekeres
2010
Corpus ID: 79075686
Abstract 4033 Background: DNMTIs are the most commonly used disease modifying agents for myelodysplastic syndromes (MDS…
Expand
2007
2007
Targets of epigenetic therapy – Gene reactivation as a novel approach in MDS treatment
R. Claus
,
B. Rüter
,
M. Lübbert
2007
Corpus ID: 72805287
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE